Atlas Venture Fund XI, L.P. - 13 Jul 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
10%+ Owner
Signature
Atlas Venture Fund XI, LP, By: Atlas Venture Associates XI, L.P., it's general partner, By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer, /s/ Ommer Chohan
Issuer symbol
DYN
Transactions as of
13 Jul 2021
Net transactions value
$0
Form type
4
Filing time
15 Jul 2021, 16:33:51 UTC
Previous filing
26 May 2021
Next filing
21 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Other $0 -814,013 -10% $0.000000 7,326,117 13 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XI pursuant to Rule 10b5-1 on June 11, 2021.